TITLE:
      The Protection Effect of Speeda® Rabies Vaccine for Human Use
SUMMARY:
      The objective of this study was to achieve the post-marketing protective effect research of
      Speeda® rabies vaccine for human use from Chengda Bio.
DETAILED DESCRIPTION:
      When found the injury who is bitten by the animal to three-level, the investigators would
      enroll the participant after explaining the protection and making him signed the informed
      consent. The patient would inject rabies vaccine as follow the national regulation,
      meanwhile the investigators would get the blood samples to detect whether the man-killer
      carries the rabies virus.
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

          -  Parent/legal acceptable representatives of children or the adult participants are
             willing and able to understand the protocol requirements and provide informed consent
             signed

          -  Participant is considered to be in good health including the body and mental status
             on the basis of reported medical history and limited physical examination and live in
             local ≥ 12 months before injured

          -  The man-killer could found and detect whether it carries the virus

        Exclusion Criteria:

          -  Known bleeding disorder or suspected impairment of immunologic function, or receipt
             of immunosuppressive therapy or immunoglobulin since birth

          -  Apply passive immunity preparation
